FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 1, 2018--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Jacqueline K.
Barton, Ph.D., has been appointed to the company’s Board of Directors.
She previously served on Gilead’s Scientific Advisory Board from 1989 to
2007.
Dr. Barton is the John G. Kirkwood and Arthur A. Noyes Professor of
Chemistry and Norman Davidson Leadership Chair of the Division of
Chemistry and Chemical Engineering at the California Institute of
Technology, where she has been a faculty member for nearly 30 years. She
served on the Board of Directors of the Dow Chemical Company from 1993
to 2017, and currently is a member of the Materials Science Advisory
Committee of DowDuPont, Inc. She founded and served on the Board of
GeneOhm Sciences, Inc., a molecular diagnostic company acquired by
Becton Dickinson and Company. She is a member of the National Academy of
Sciences, the National Academy of Medicine and the American
Philosophical Society. In 2011, Dr. Barton received the National Medal
of Science for her discovery of new chemistry of the DNA helix.
“We are very pleased to welcome Jacqueline Barton to the Board of
Directors of Gilead Sciences,” said John Milligan, Ph.D., President and
Chief Executive Officer, Gilead Sciences. “Jackie is one of the most
decorated chemists in America and was awarded the Priestley Medal from
the American Chemical Society, its highest honor. Her deep knowledge of
scientific discovery in both academic and industry settings will help
guide our long-term strategy as Gilead continues to translate science
into better solutions for patients.”
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Gilead has operations in more
than 35 countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180201006478/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.Sung Lee, 650-524-7792InvestorsorMichele
Rest, 650-577-6935Media
